CClinicalTrials.gg
Active, not recruitingNCT06259253Updated Sep 17, 2026

Understanding Patient Experience Among Asians at MD Anderson

An observational study in Cancer, sponsored by M.D. Anderson Cancer Center. Active, not recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-17.

Sponsored by M.D. Anderson Cancer Center · Observational

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
520
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this research study is to understand barriers to and facilitators of a positive patient experience for Asian patients.

Read the detailed description

Primary Objective:

a. Identify critical aspects of inpatient experience among former Asian/Asian American patients at MD Anderson.

Secondary Objectives:

a. Determine MD Anderson health care providers' perceptions of Asian/Asian American inpatient experience.

02

Conditions studied

  • Cancer

Browse trials for

03

In context

Neoplasms

9,365 studies on the registry are indexed under Neoplasms; 2,489 are open to participants now.

This study's planned enrollment of 520 is above the median of 204 across 1,683 observational studies indexed under Neoplasms.

Browse Neoplasms studies →

Lead sponsor

M.D. Anderson Cancer Center is the lead sponsor of 2,999 studies on the registry; 581 are open to participants now.

Of its 599 completed or terminated interventional studies of FDA-regulated products, 402 (67%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

MD Anderson Cancer Center Participants

Eligibility criteria

Inclusion criteria for former patients:

  • Self-identify as Asian/Asian American
  • Are 18 years or older
  • Have been diagnosed with cancer, any type
  • Received inpatient care at MD Anderson between 2019 and 2022
  • Have a U.S. address
  • Can read and write in English or simplified Chinese

Exclusion criteria for former patients:

  • None

Inclusion criteria for healthcare providers:

  • Self-report as a practicing provider at MD Anderson
  • Provided treatment services to Asian/Asian American patients between 2019 and 2022

Exclusion criteria for healthcare providers:

  • None
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
520 participants (estimated)
Patient registry
No

Groups and cohorts

  • Observational Cohort 1 - Patient/Provider

    Participant will complete a computer-based questionnaire about your age, gender, income, highest level of education, patient experience, medical mistrust, social support and health care access.

  • Observational Cohort 2 - Patient/Provider

    Participant will complete a computer-based questionnaire about your age, gender, income, highest level of education, patient experience, medical mistrust, social support and health care access.

06

What researchers measure

Primary outcomes

  1. Picker Patient Experience Questionnaire (PPE-15)

    Time frame: Through study completion; an average of 1 year

07

Study locations

1 site
  • MD Anderson Cancer Center
    Houston, Texas 77030, United States
08

References and documents

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06259253
Lead sponsor
M.D. Anderson Cancer Center
Responsible party
Sponsor
First posted
Feb 14, 2024
Start date
Apr 24, 2024
Primary completion
Jul 1, 2030 (estimated)
Completion
Jul 1, 2030 (estimated)
Last update
Sep 17, 2026

Study contacts

Lorna McNeill, MPH,PHD
principal investigator · M.D. Anderson Cancer Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion